Antibody Response to the BA.5 Bivalent Vaccine Shot: a Two-Year Follow-Up Study following Initial COVID-19 mRNA Vaccination-Reference-Cited by-同舟云学术

Antibody Response to the BA.5 Bivalent Vaccine Shot: a Two-Year Follow-Up Study following Initial COVID-19 mRNA Vaccination

Author:

Hirotsu Yosuke¹^ORCID,Sugiura Hiroki²,Takatori Mika³,Mochizuki Hitoshi¹⁴⁵,Omata Masao⁵⁶

Affiliation:

1. Genome Analysis Center, Yamanashi Central Hospital, Kofu, Japan

2. Division of Clinical Biochemistry and Immunology, Yamanashi Central Hospital, Kofu, Japan

3. Division of Infection Control and Prevention, Yamanashi Central Hospital, Kofu, Japan

4. Central Clinical Laboratory, Yamanashi Central Hospital, Kofu, Japan

5. Department of Gastroenterology, Yamanashi Central Hospital, Kofu, Japan

6. The University of Tokyo, Tokyo, Japan

Abstract

A COVID-19 bivalent mRNA vaccine was developed and administered to health care workers. The COVID-19 mRNA vaccine induces a robust antibody response.

Funder

MEXT | Japan Society for the Promotion of Science

Yasuda Memorial Medical Foundation

Takeda Medical Research Foundation

Uehara Memorial Foundation

Kato Memorial Bioscience Foundation

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Link

Reference21 articles.